Recerca > Medicina i teràpia experimental

Patologia oncològica

Nombre de publicacions
416
Cercador de publicacions
  • Rodriguez-Hernandez I; Maiques O; Kohlhammer L; Cantelli G; Perdrix-Rosell A; Monger J; Fanshawe B; Bridgeman VL; Karagiannis SN; Penin RM; Marcolval J; Marti RM; Matias-Guiu X; Fruhwirth GO; Orgaz JL; Malanchi I; Sanz-Moreno V

    WNT11-FZD7-DAAM1 signalling supports tumour initiating abilities and melanoma amoeboid invasion.

    Nature Communications 11 5315-5315. .

    [doi:10.1038/s41467-020-18951-2]

  • Blasco N; Beà A; Barés G; Girón C; Navaridas R; Irazoki A; López-Lluch G; Zorzano A; Dolcet X; Llovera M; Sanchis D

    Involvement of the mitochondrial nuclease EndoG in the regulation of cell proliferation through the control of reactive oxygen species

    Redox Biology 37 101736-101736. .

    [doi:10.1016/j.redox.2020.101736]

  • Cuatrecasas M; Gorostiaga I; Riera C; Saperas E; Llort G; Costa I; Matias-Guiu X; Carrato C; Navarro M; Pineda M; Dueñas N; Brunet J; Marco V; Trias I; Busteros JI; Mateu G; Balaguer F; Fernández-Figueras MT; Esteller M; Musulén E

    Complete Loss of EPCAM Immunoexpression Identifies EPCAM Deletion Carriers in MSH2-Negative Colorectal Neoplasia.

    Cancers 12 -. .

    [doi:10.3390/cancers12102803]

  • Megino-Luque C; Moiola CP; Molins-Escuder C; López-Gil C; Gil-Moreno A; Matias-Guiu X; Colas E; Eritja N

    Small-Molecule Inhibitors (SMIs) as an Effective Therapeutic Strategy for Endometrial Cancer.

    Cancers 12 -. .

    [doi:10.3390/cancers12102751]

  • López-Cano C; Gutiérrez-Carrasquilla L; Barbé F; Sánchez E; Hernández M; Martí R; Ceperuelo-Mallafre V; Dalmases M; Fernández-Veledo S; Vendrell J; Hernández C; Simó R; Lecube A

    Effect of Type 2 Diabetes Mellitus on the Hypoxia-Inducible Factor 1-Alpha Expression. Is There a Relationship with the Clock Genes?

    Journal of Clinical Medicine 9 -. .

    [doi:10.3390/jcm9082632]

  • Bonet, M; Rodrigo, A; Vázquez S; Carrizo, V; Vilardell, F; Mira, M

    Adjuvant therapy for true ampullary cancer: a systematic review.

    CLINICAL & TRANSLATIONAL ONCOLOGY 22 1407-1413. .

    [doi:10.1007/s12094-019-02278-6]

  • Da Cruz Paula A; da Silva, EM; Segura, SE; Pareja, F; Bi, R; Selenica, P; Kim, SH; Ferrando, L; Vahdatinia, M; Soslow, RA; Vidal, A; Gatius, S; Przybycin, CG; Abu-Rustum, NR; Matias-Guiu, X; Rubin, BP; Reis, JS; DeLair, DF; Weigelt, B

    Genomic profiling of primary and recurrent adult granulosa cell tumors of the ovary.

    Modern Pathology 33 1606-1617. .

    [doi:10.1038/s41379-020-0514-3]

  • Damaso, E; Gonzalez-Acosta, M; Vargas-Parra, G; Navarro, M; Balmaña J; Ramon Y Cajal T; Tuset, N; Thompson, BA; Marin, F; Fernandez, A; Gomez, C; Velasco À; Solanes, A; Iglesias, S; Urgel, G; Lopez, C; del Valle, J; Campos, O; Santacana, M; Matias-Guiu, X; Lazaro, C; Valle, L; Brunet, J; Pineda, M; Capella, G

    Comprehensive Constitutional Genetic and Epigenetic Characterization of Lynch-Like Individuals.

    Cancers 12 1799-. .

    [doi:10.3390/cancers12071799]

  • Matias-Guiu X

    Nuevos tiempos, nuevas prioridades.

    Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia 53 137-137. .

    [doi:10.1016/j.patol.2020.05.002]

  • Mayo-de-las-Casas, C; Velasco, A; Sanchez, D; Martínez-Bueno A; Garzón-Ibáñez M; Gatius, S; Ruiz-Mir?, M; Gonzalez-Tallada, X; Llordella, I; Tresserra, F; Rodríguez S; Aldeguer, E; Roman-Canal, B; Bertran-Alamillo, J; García-Peláez B; Rosell, R; Molina-Vila, MA; Matias-Guiu, X

    Detection of somatic mutations in peritoneal lavages and plasma of endometrial cancer patients: a proof-of-concept study.

    INTERNATIONAL JOURNAL OF CANCER 147 277-284. .

    [doi:10.1002/ijc.32872]

  • Alonso-Alconada, L; de la Fuente, A; Santacana, M; Ferreiros, A; Lopez-Lopez, R; Matias-Guiu, X; Abal, M

    Biomimetic device and foreign body reaction cooperate for efficient tumour cell capture in murine advanced ovarian cancer.

    DISEASE MODELS & MECHANISMS 13 dmm043653-. .

    [doi:10.1242/dmm.043653]

  • Lahiguera Á; Hyroššová P; Figueras A; Garzón D; Moreno R; Soto-Cerrato V; McNeish I; Serra V; Lazaro C; Barretina P; Brunet J; Menéndez J; Matias-Guiu X; Vidal A; Villanueva A; Taylor-Harding B; Tanaka H; Orsulic S; Junza A; Yanes O; Muñoz-Pinedo C; Palomero L; Pujana MÀ; Perales JC; Viñals F

    Tumors defective in homologous recombination rely on oxidative metabolism: relevance to treatments with PARP inhibitors.

    Embo Molecular Medicine 12 e11217-. .

    [doi:10.15252/emmm.201911217]